Table 1 Demographic and Clinical Characteristics of the Sample

From: Protracted amygdalar response predicts efficacy of a computer-based intervention targeting attentional patterns in transdiagnostic clinical anxiety

 

ABM (n = 39)

Sham (n = 19)

 

Pre-treatment

Post-treatment

Pre-treatment

Post-treatment

Demographics:

Caucasian, n (%)

24 (62%)

–

14 (74%)

–

Female, n (%)

29 (74%)

–

14 (74%)

–

Age

29.72 (8.48)

–

30.74 (12.13)

–

Primary outcome measures

MASQ: Anxious Arousal

32.97 (10.99)

28.54 (9.75)

33.47 (11.04)

29.90 (13.61)

CAPS: Vigilance

4.72 (2.01)

4.08 (1.98)

5.21 (2.30)

4.05 (2.07)

  1. Data presented as mean (SD) unless otherwise noted. MASQ Mood and Anxiety Symptoms Questionnaire, CAPS Clinician-Administered PTSD Scale
Back to article page